Related Experiment Video
Updated: Jun 13, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Managing type 2 diabetes: balancing HbA1c and body weight
Annie A Mavian1, Stephan Miller, Robert R Henry
1Division of Endocrinology, Diabetes and Metabolism, University of California San Diego, San Diego, CA 92103, USA.
Postgraduate Medicine
|May 14, 2010
Summary
Managing type 2 diabetes in overweight patients is challenging as many medications cause weight gain. Some newer treatments offer glycemic control with weight neutrality or loss, aiding overall patient health.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 2 diabetes often coexists with overweight/obesity, complicating glycemic control.
- Weight gain from common diabetes medications like insulin and sulfonylureas exacerbates health risks.
- Emerging therapies offer weight-neutral or weight-loss benefits alongside glycemic improvement.
Purpose of the Study:
- To evaluate the comparative glycemic benefits and body weight effects of approved type 2 diabetes medications.
- To inform medication selection for patients with type 2 diabetes, considering weight management goals.
Main Methods:
- Review of clinical trial evidence on glycated hemoglobin (HbA1c) changes and body weight impact.
- Analysis of medications including sulfonylureas, thiazolidinediones, biguanides, DPP-4 inhibitors, incretin mimetics, and amylin mimetics.
- Inclusion of trials for weight loss agents (orlistat, sibutramine) in diabetes management.
Main Results:
- Sulfonylureas, thiazolidinediones, and D-phenylalanine derivatives are associated with weight gain.
- Biguanides, incretin mimetics, and amylin mimetics promote weight loss.
- Dipeptidyl peptidase-4 inhibitors demonstrate weight neutrality.
Conclusions:
- Medication choice in type 2 diabetes impacts glycemic control and body weight.
- Weight-neutral or weight-loss medications can support comprehensive management in overweight/obese patients.
- Evidence-based selection of antidiabetic drugs is crucial for achieving both glycemic and weight goals.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...